Compare ResMed Inc. (RMD) vs Teucrium Wheat Fund (WEAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Teucrium Wheat Fund — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Teucrium Wheat Fund trades at $25.21. The key difference: ResMed Inc. pays a 1.21% dividend while Teucrium Wheat Fund pays none, and Teucrium Wheat Fund is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | WEAT | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $293.73 | $25.49 |
52-Week Low | $182.82 | $19.88 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WEAT trades at $24.99, down 1.03% in the last session, with technical indicators showing a mixed but overall bullish bias. The USDA's reduced 2026 wheat production forecast to 1.56 billion bushels (WSJ, 2026-05-12) and recent wheat price volatility highlight fundamental supply-side influences. Moving averages signal strong bullish momentum, though oscillators indicate near-term overbought conditions.
The outlook for WEAT is cautiously optimistic, driven by agricultural commodity trends and supportive technicals. Key opportunities include exposure to wheat price appreciation, but risks involve weather impacts on crops, inflation fluctuations, and competitive ETF pressure as noted in recent coverage (24/7 Wall Street, 2026-05-16).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Teucrium Wheat Fund
WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →
